CNS5:Volunteer Assignments and Opportunities: Difference between revisions

To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />

{| class="wikitable" style="margin:auto"

|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>

!'''Date of Last Editor Review'''

!'''Notes'''

|-

|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]

|6/25/2023

|

|

|Laveniya Satgunaseelan (LS)

|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]

|Disease

|6/7/2022

|

|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]

|Disease

|PENDING

|

|LS

|

|-

|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]

|6/27/2023

|

|

|LS

|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]

|Disease

|

|

|

|

|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]

|Disease

|

|

|

|LS

|

|2021 template added

|-

|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]

|

|

|-

|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]

|Disease

|

|PENDING

|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]

|Disease

|

|

|

|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]

|Disease

|

|LS

|

|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]

|Disease

|

|

|

|

|

|-

|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]

|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]

|Disease

|

|-

|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]

|

|

|-

|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]

|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]

|Disease

|

|

|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]

|Disease

|

|

|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]

|Disease

|

|

|

|

|-

|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]

|

|

|-

|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]

|

|

|-

|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]

|Disease

|9/20/21

|

|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]

|Disease

|

|

|

|

|-

|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]

|

|-

|

|

|

|

|

|

|

|

|-

|Disease

|

|

|-

|Disease

|

|

|

|

|

|

|-

|

|

|

|

|

|

|

|

|-

|[[CNS5:Neurofibroma|Neurofibroma]]

|Disease

|

|-

|[[CNS5:Perineurioma|Perineurioma]]

|Disease

|

|-

|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]

|Disease

|

|

|

|-

|Disease

|

|

|-

|

|

|

|

|

|

|

|

|-

|Disease

|

|

|-

|

|

|

|

|

|

|

|

|-

|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]

|Disease

|

|-

|

|

|-

|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]

|Disease

|

|-

|-

|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]

|Disease

|

|

|-

|Disease

|

|

|-

|

|

|

|

|

|

|

|

|-

|Disease

|

|

|-

|Disease

|

|

|-

|

|

|

|

|

|

|

|

|-

|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]

|

|

|-

|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]

|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]

|Disease

|

|-

|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]

|Disease

|

|-

|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]

|Disease

|

|-

|MS

|

|-

|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]

|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]

|Disease

|

|-

|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]

|Disease

|

|-

|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]

|Disease

|

|

|

|

|

|

|

|

|

|

|

|

|

|-

|Disease

|

|

|-

|

|

|

|

|

|

|

|

|-

|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]

|

|-

|

|

|

|

|

|

|

|

|-

|Disease

|

|

|-

|Disease

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|-

|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]

|Disease

|

|-

|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]

|Disease

|

|-

|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]

|Disease

|

|-

|[[CNS5:Cowden_syndrome|Cowden syndrome]]

|Disease

|

|-

|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]

|Disease

|

|-

|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]

|Disease

|

|-

|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]

|Disease

|

|-

|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]

|Disease

|

|-

|[[CNS5:Carney_complex|Carney complex]]

|Disease

|

|-

|[[CNS5:DICER1_syndrome|DICER1 syndrome]]

|Disease

|

|-

|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]

|Disease

|

|-

|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]

|Disease

|

|-

|

|

|-

|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]

|Disease

|

|-

|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]

|Disease

|

|-

|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]

|Disease

|

|-

|}